Biotech and Pharmaceuticals
New Covid vaccines could reach Americans as soon as Thursday – here’s what you need to know
A nurse prepares doses of the Pfizer vaccine during a COVID-19 vaccination event at Josephine’s Southern Cooking in Chatham, Illinois, Dec. 30, 2021. Brian Cassella | Tribune News Service | Getty Images A new round of Covid vaccines is finally here in the U.S. The Centers for Disease Control and Prevention cleared single-strain shots from […]
Read More
Moderna says flu vaccine showed promising results in phase three trial, paving path to approval
A nurse prepares a flu shot at Huntington Village Pediatrics, in Huntington, New York on December 8, 2021. Steve Pfost | Newsday | Getty Images Moderna on Wednesday said its experimental mRNA-based flu vaccine produced a stronger immune response against four strains of the virus than a currently available flu vaccine in a late-stage trial, […]
Read More
CDC advisors recommend updated Covid vaccines for all Americans ages 6 months and up
A vial of the Moderna coronavirus booster vaccine targeting BA.4 and BA.5 Omicron subvariants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, Sept. 8, 2022. Hannah Beier | Reuters An independent advisory panel to the Centers for Disease Control and Prevention on Tuesday recommended that all Americans ages 6 months and up receive updated Covid […]
Read More
Decongestant found in many cold, allergy medicines doesn’t actually work, FDA advisors say
A combination package of Procter & Gamble Co. DayQuil Severe and NyQuil Severe brand cold and flu medicine is arranged for a photograph in Tiskilwa, Illinois. Daniel Acker | Bloomberg | Getty Images The main ingredient used in many popular over-the-counter cold and allergy medications doesn’t actually work to get rid of nasal congestion, an […]
Read More
Wager in opposition to America’s enjoy for junk food stuff? Morgan Stanley sees hard periods forward for snack stocks like Hostess
J.M. Smucker ‘s prepare to obtain Twinkies -maker Hostess Models is a risky shift, if Morgan Stanley’s most current investigate is appropriate. The company revisited its August call that a new course of body weight loss medicines would hamper expansion at some foodstuff and beverage firms . This time it backed up its thesis with […]
Read More
FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations rise
A health-care worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The Food and Drug Administration on Monday approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach […]
Read More
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here’s what we know
An Ozempic (semaglutide) injection pen is seen on a kitchen table in Riga, Latvia on 06 August, 2023. Jaap Arriens | Nurphoto | Getty Images Heather Le Biller shed 9 pounds within the first week of taking Novo Nordisk‘s blockbuster diabetes drug Ozempic – and then even more as she continued treatment. Le Biller, a […]
Read More
Big pharma’s blockbuster obesity drug battle is just getting started, and it’s headed for $100 billion
Ozempic drug to treat diabetes. Courtesy: Ozempic In their most recent earnings reports, Novo Nordisk and Eli Lilly proved why they are the undisputed heavyweights in the prizefight for control of the rapidly growing weight-loss medications market. Beyond staggering sales figures for Novo’s Ozempic and Wegovy and Lilly’s Mounjaro, news of a study showing Wegovy […]
Read More
Two 9/11 victims discovered much more than two a long time following World Trade Middle attacks
Smoke pours from the Twin Towers of the Earth Trade Center right after they have been hit by two hijacked airliners in a terrorist attack in New York Metropolis, Sept. 11, 2001. Robert Giroux | Getty Visuals Two victims who perished in the Earth Trade Heart have been discovered more than two many years immediately […]
Read More
Obesity drugs’ popularity put a dent in these stocks. Why analysts say they’re still worth buying
Industry analysts are insisting that new weight loss and diabetes drugs like Ozempic won’t hurt the demand for insulin pumps and continuous glucose monitors, but most investors aren’t buying it. Medical device stocks have been falling session after session, prompting UBS analyst Danielle Antalffy on Wednesday to lower her price targets for Dexcom and a […]
Read More